V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002525 | 250009167 | 1.74 | 85.9 | null | 2022-02-13 | 2022-03-16 | GemCarbo Days 1+8 | 02 | null | ATEZOLIZUMAB | 100606801 |
| 250002533 | 250009170 | 1.7 | 100.6 | null | 2020-02-01 | 2020-02-01 | BCG Intravesical | N | N | ENZALUTAMIDE | 101026923 |
| 250002537 | 250009171 | 0 | 96.6 | null | 2020-02-28 | 2020-02-28 | null | 02 | N | CISPLATIN | 100221084 |
| 250002541 | 250009172 | 1.32 | 83 | Curative (C) | 2020-09-21 | 2020-09-21 | null | 02 | N | TRIAL UNSPECIFIED | 100870402 |
| 250000284 | 250009173 | 1.83 | 72 | Palliative (P) | 2020-01-15 | 2020-01-18 | null | 02 | N | CARBOPLATIN + VINORELBINE | 101298839 |
| 250000718 | 250009175 | 1.65 | 66.8 | Palliative (P) | 2019-11-11 | 2019-12-10 | Cetuximab + CISPLATIN + FLUOROURACIL | 01 | null | IMATINIB | 100876386 |
| 250000744 | 250009176 | 1.05 | 74 | Curative (C) | 2022-03-02 | 2022-03-21 | null | 02 | null | CAPECITABINE + IRINOTECAN | 101856875 |
| 250000771 | 250009178 | 1.68 | 43.8 | Palliative (P) | 2021-04-19 | 2021-04-27 | null | 02 | N | VINCRISTINE | 101609837 |
| 250000823 | 250009180 | null | null | Palliative (P) | null | 2020-07-04 | NB HRNBL-1 BUMEL MAT | null | N | CARBOPLATIN + FLUOROURACIL | 100791807 |
| 250000920 | 250009181 | null | null | Palliative (P) | 2018-10-26 | 2018-11-06 | CABOZANTINIB | 01 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100989360 |
| 250001074 | 250009184 | 1.83 | 11.2 | Palliative (P) | null | 2018-05-13 | null | 02 | N | WT SIOP 2002 01 POST OP CARBO, ETOP | 100864065 |
| 250001092 | 250009185 | null | null | null | null | 2020-05-02 | Liposomal Doxorubicin 40mg/m2 | null | N | CAPECITABINE + CARBOPLATIN | 100809939 |
| 250001131 | 250009186 | 1.76 | 52 | Palliative (P) | 2020-07-27 | 2020-07-27 | AVAPRITINIB | 02 | N | TRIAL UNSPECIFIED | 100206432 |
| 250001208 | 250009188 | 1.64 | 70.2 | null | 2019-12-11 | 2019-12-14 | null | 02 | null | ICON8B TRIAL | 101544258 |
| 250001331 | 250009189 | 1.66 | 63.8 | Neo-adjuvant (N) | 2022-02-05 | 2022-02-23 | Cyclophosphamide oral | 02 | null | SUNITINIB | 100604720 |
| 250001632 | 250009192 | 1.66 | 51.2 | Neo-adjuvant (N) | 2022-04-11 | 2022-04-13 | Liposomal Doxorubicin 40mg/m2 | 02 | N | CAPECITABINE + OXALIPLATIN | 101058742 |
| 250001793 | 250009194 | 1.1 | 61 | Palliative (P) | null | 2021-09-30 | AVELUMAB + AXITINIB | 02 | null | TRIAL UNSPECIFIED | 100602541 |
| 250001892 | 250009196 | 1.74 | 54.5 | Neo-adjuvant (N) | null | 2020-04-22 | null | null | N | CABOZANTINIB | 101074705 |
| 250002275 | 250009198 | 1.56 | 74.8 | null | null | 2019-10-11 | Carboplatin + Pemetrexed | 02 | null | IMATINIB | 100548739 |
| 250002254 | 250009228 | 1.59 | null | null | null | 2020-08-23 | NIVOLUMAB | null | null | NIVOLUMAB | 100575057 |
| 250002272 | 250009229 | 1.73 | 124.3 | null | null | 2020-03-02 | null | null | null | CISPLATIN + GEMCITABINE | 100196390 |
| 250002279 | 250009230 | 1.71 | 95.9 | null | 2020-04-08 | 2020-05-01 | CISPLATIN + GEMCITABINE | 02 | null | NIVOLUMAB | 101420799 |
| 250002294 | 250009231 | 1.78 | 104 | null | null | 2018-10-20 | null | null | null | NIVOLUMAB | 101014106 |
| 250002309 | 250009232 | 1.62 | 79.1 | null | null | 2019-04-26 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101720961 |
| 250002313 | 250009233 | 1.78 | 59.4 | Neo-adjuvant (N) | 2019-05-15 | 2019-05-19 | null | 02 | N | PEMBROLIZUMAB | 101535452 |
| 250002319 | 250009234 | 1.68 | 71 | null | null | 2019-07-31 | null | null | null | CARBOPLATIN + GEMCITABINE | 101205298 |
| 250002332 | 250009235 | 1.81 | 68 | Palliative (P) | 2018-06-18 | 2018-07-01 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101666138 |
| 250002335 | 250009237 | 1.66 | 58 | null | null | 2020-06-20 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100304734 |
| 250002360 | 250009238 | 1.85 | 93.6 | null | null | 2020-12-07 | null | null | null | NIVOLUMAB | 101227963 |
| 250002383 | 250009239 | 1.63 | 75 | null | null | 2021-01-14 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 101814106 |
| 250002412 | 250009242 | 1.57 | 60.8 | null | null | 2018-12-07 | NIVOLUMAB | null | null | NIVOLUMAB | 101613599 |
| 250002503 | 250009247 | 1.67 | 84 | Palliative (P) | 2020-08-04 | 2020-08-18 | CNS HGG Temozolomide +XRT | 02 | N | PAZOPANIB | 101081853 |
| 250002505 | 250009248 | 1.79 | 87 | Palliative (P) | 2020-09-07 | 2020-10-30 | GEMCITABINE + RT | 02 | Y | GEMCITABINE + NAB-PACLITAXEL | 100572530 |
| 250002533 | 250009252 | 1.82 | 71.3 | null | 2020-02-08 | 2020-02-09 | null | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101026923 |
| 250000718 | 250009255 | 1.6 | 0 | null | null | 2019-12-06 | Carboplatin + Pemetrexed | 01 | N | TRIAL UNSPECIFIED | 100876386 |
| 250000744 | 250009256 | null | null | Palliative (P) | null | 2022-05-21 | Trabectedin | null | N | TRIAL UNSPECIFIED | 101856875 |
| 250000823 | 250009259 | 1.78 | 73.5 | null | null | 2020-07-05 | CARBOPLATIN + ETOPOSIDE | N | N | VINORELBINE | 100791807 |
| 250000974 | 250009261 | null | 92.6 | null | null | 2020-06-14 | null | 02 | null | PACLITAXEL | 101827919 |
| 250001057 | 250009262 | null | null | Curative (C) | 2020-10-11 | 2020-10-11 | null | N | null | CISPLATIN | 101410777 |
| 250001131 | 250009265 | 1.67 | null | null | 2020-08-25 | 2020-08-25 | null | 02 | N | ATEZOLIZUMAB | 100206432 |
| 250001208 | 250009266 | 1.67 | null | null | 2019-12-18 | 2020-02-16 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | null | ABIRATERONE | 101544258 |
| 250001331 | 250009267 | 1.61 | 54.5 | Palliative (P) | 2022-03-02 | 2022-03-06 | null | 02 | N | STS NON-RHABDO EPSSG 2005 IE | 100604720 |
| 250001358 | 250009268 | 1.76 | 91 | Palliative (P) | 2020-01-01 | 2020-01-01 | CABOZANTINIB | 02 | null | CISPLATIN + FLUOROURACIL | 100992873 |
| 250001632 | 250009269 | 1.6 | null | null | 2022-05-09 | 2022-05-18 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | CARBOPLATIN + PACLITAXEL | 101058742 |
| 250001692 | 250009270 | 0 | 72.3 | Disease modification (D) | 2021-11-24 | 2022-02-21 | CARBOPLATIN | 02 | N | CISPLATIN | 100928227 |
| 250001793 | 250009271 | 1.81 | 104.1 | Palliative (P) | 2021-11-21 | 2021-11-30 | CARBOPLATIN | 02 | Y | WT SIOP 2002 01 POST OP CARBO, ETOP | 100602541 |
| 250002275 | 250009273 | 1.8 | 71 | null | null | 2019-10-21 | STS Rhabdomyosarcoma RMS 2005 IVA | 2 | N | CISPLATIN | 100548739 |
| 250002254 | 250009294 | 1.8 | 80 | null | null | 2020-08-23 | null | null | null | CARBOPLATIN + GEMCITABINE | 100575057 |
| 250002319 | 250009299 | 1.67 | 54.3 | null | null | 2019-07-31 | null | null | null | CARBOPLATIN + GEMCITABINE | 101205298 |
| 250002334 | 250009300 | 1.84 | 129 | Palliative (P) | 2020-03-04 | 2020-03-16 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101637139 |